Estrogen-containing Hormonal Contraceptives May Prevent Additional Breast Hypertrophy in Adolescents with Macromastia

被引：0
|
作者：
McNamara, Catherine [1 ]
Nuzzi, Laura [1 ]
Massey, Gabrielle [1 ]
Pramanick, Tannishtha [1 ]
Firriolo, Joseph [1 ]
Labow, Brian [1 ]
机构：
[1] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
787015
引用
收藏
页码：S576 / S576
页数：1
相关论文
共 29 条
  • [21] EXPERIMENTAL VITAMIN-B6 DEFICIENCY AND EFFECT OF ESTROGEN-CONTAINING ORAL-CONTRACEPTIVES ON TRYPTOPHAN METABOLISM AND VITAMIN-B6 REQUIREMENTS
    ROSE, DP
    STRONG, R
    HARDING, PE
    ADAMS, PW
    CLINICAL SCIENCE, 1972, 42 (04) : 465 - &
  • [22] Current use of estrogen-containing oral contraceptives or hormone therapy and risk of COVID-19 infection and hospitalization: a population-based cohort study
    Harrington, Laura B.
    Powers, J. David
    Bayliss, Elizabeth A.
    Fortmann, Stephen P.
    Shortreed, Susan M.
    Walker, Rod L.
    Floyd, James S.
    Kuntz, Jennifer
    Fuller, Sharon
    Alberston-Junkans, Ladia
    Lee, Mi H.
    Temposky, Lisa A.
    Dublin, Sascha
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2024, 193 (10) : 1417 - 1425
  • [23] ACTIVATED FACTOR-X-ANTITHROMBIN-III REACTION-RATE - A MEASURE OF INCREASED THROMBOTIC TENDENCY INDUCED BY ESTROGEN-CONTAINING ORAL-CONTRACEPTIVES IN RABBITS
    GITEL, SN
    STEPHENSON, RC
    WESSLER, S
    HAEMOSTASIS, 1978, 7 (01) : 10 - 18
  • [24] A rare case of catastrophic antiphospholipid syndrome triggered by estrogen-containing oral contraceptives in a patient with double heterozygous factor V Leiden and prothrombin G20210A mutations
    McRae, Hannah L.
    Yang, Annie H.
    Kruzer, Karen
    Scott, Glynis A.
    Refaai, Majed A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (02) : 239 - 242
  • [25] Adjuvant trastuzumab use in high-risk breast cancer patients may prevent development of contralateral estrogen receptor-negative breast tumors
    Altundag, K
    Altundag, O
    Islam, R
    Gundeslioglu, O
    MEDICAL HYPOTHESES, 2006, 66 (05) : 1045 - 1046
  • [26] Effects of A Breast-Health Herbal Formula Supplement on Estrogen Metabolism in Pre- and Post-Menopausal Women not Taking Hormonal Contraceptives or Supplements: A Randomized Controlled Trial
    Laidlaw, Maggie
    Cockerline, Carla A.
    Sepkovic, Daniel W.
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2010, 4 : 85 - 95
  • [27] Effects of a Breast-Health Herbal Formula Supplement on Estrogen Metabolism in Pre- and Post-Menopausal Women Not Taking Hormonal Contraceptives or Supplements: A Randomized Controlled Trial
    Laidlaw, Maggie
    Cockerline, Carla
    Sepkovic, Daniel
    JOURNAL OF WOMENS HEALTH, 2011, 20 (03) : 490 - 491
  • [28] Effects of a Breast-Health Herbal Formula Supplement of Estrogen Metabolism in Pre- and Post- Menopausal Women not Taking Hormonal Contraceptives or supplements: A Randomized Controlled Trial (vol 4, pg 85, 2010)
    Laidlaw, Maggie
    Cockerline, Carla A.
    Sepkovic, Daniel W.
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2012, 6 : 101 - 101
  • [29] Adjuvant Trastuzumab Effect on HER2-Positive Breast Cancers According to Hormonal Receptor (HR) Status: Crosstalk between ER and EGFR/HER2 Pathway May Prevent Trastuzumab from Improving Outcomes in HER2-Positive and HR-Positive Breast Cancers
    Park, Y. H.
    Choi, E. Y.
    Lee, J. E.
    Nam, S. J.
    Yang, J. H.
    Ahn, J. S.
    Im, Y-H
    CANCER RESEARCH, 2011, 71
123